FACTORY-DIRECT RESEARCH MATERIALS
ManufacturingResourcesProject enquiries
Pepverlabs Request a quote

TR10 |Tirzepatide | 10mg*10vials| >99% Purity

(80 customer reviews)

Tirzepatide is described as a peptide with activity at both GIP and GLP-1 receptors. TR10 is the source catalog identifier for this research-material listing.

Product Name
TR10 Tirzepatide
CAS Number
2141034-80-7
Molecular Formula
C225H348N48O67
Purity (HPLC)
≥ 99.0%
Molecular weight
4813.5
pH Level
4.2–5.2 (Acetic acid buffer system)
Storage
Store at 20°C to 25°C (Do not freeze)

Available specifications

5 mg × 10 vials10 mg × 10 vials15 mg × 10 vials20 mg × 10 vials30 mg × 10 vials40 mg × 10 vials50 mg × 10 vials60 mg × 10 vials100 mg × 10 vials120 mg × 10 vials

Request a quotation for your preferred specification and quantity.

Add to your enquiry

Description

Basic introduction

Tirzepatide is a synthetic peptide investigated through both GIP and GLP-1 receptor pathways. Its structure includes a lipid modification, which is relevant to the pharmacological preparation described in the scientific literature.

The research spans receptor assays, animal models and clinical studies. These evidence levels should remain separate: a receptor response characterizes one aspect of a molecule, while a clinical study concerns a defined formulation, population and protocol.

Mechanism of action · Research context

GIP receptor response

Tirzepatide was characterized as a GIP receptor agonist. Receptor-specific assays help define this activity independently of its response at the GLP-1 receptor.

GLP-1 receptor response

GLP-1 receptor activity provides a second experimental pathway. Comparing signaling in matched assay systems is more informative than assuming equal activity at both receptors from the dual-agonist label alone.

Integrated metabolic effects

Whole-system responses involve more than receptor activation. The discovery program examined glucose-dependent insulin secretion and metabolic outcomes across several experimental settings.

Extended research considerations

Receptor assay controls

Identify the receptor expression system and readout. Differences in receptor abundance, assay timing or signal amplification can affect comparisons between GIP and GLP-1 responses.

Formulation and exposure

Lipid modification influences the tested preparation. Analytical identity, aggregation and compatibility with the assay medium are separate from the receptor-response result.

Clinical evidence context

Clinical trials evaluate specific pharmaceutical preparations. Their outcomes do not certify the identity, sterility or clinical suitability of a research product sold independently of those studies.

Material and packaging

Available kit specifications: 5 mg × 10 vials; 10 mg × 10 vials; 15 mg × 10 vials; 20 mg × 10 vials; 30 mg × 10 vials; 40 mg × 10 vials; 50 mg × 10 vials; 60 mg × 10 vials; 100 mg × 10 vials; 120 mg × 10 vials. Select an option above to view its current price and availability.

Storage and handling

Source-listed storage condition: Store at 20°C to 25°C (Do not freeze). Follow the handling instructions supplied with the actual batch and your laboratory's procedures.

Analytical documentation

Reference analytical documents are available with this listing. Check the material identity, batch number and test date against the batch supplied; contact us for current batch documentation.

Scientific references

These publications describe the studied molecules and experimental models. They do not certify the identity, quality or effects of a particular supplied batch.

  • Discovery and experimental characterization of LY3298176
  • Phase 2 tirzepatide clinical research

Additional information

Specification

5 mg × 10 vials, 10 mg × 10 vials, 15 mg × 10 vials, 20 mg × 10 vials, 30 mg × 10 vials, 40 mg × 10 vials, 50 mg × 10 vials, 60 mg × 10 vials, 100 mg × 10 vials, 120 mg × 10 vials

Analytical documentation

80 reviews for TR10 |Tirzepatide | 10mg*10vials| >99% Purity

  1. Dexter M. –

    My sugar cravings disappear entirely for the full seven days after each dose. The airtight vials prevent light and moisture damage during transit, and every single vial arrived intact. This peptide keeps my blood sugar steady so I never crash mid-day.

  2. Chelsea R. –

    Potency is consistent across all 10 vials, no weak doses. I only experience mild nausea in the first 24 hours after injection, and then my digestion returns fully to normal. The lyophilized powder dissolves completely, leaving zero sediment at the bottom of each vial.

  3. Gemma L. –

    No big variation between vials, the batch quality is extremely uniform. The weekly dosing fits perfectly with my busy travel schedule. Minimal side effects, reliable appetite control, and stable post-mix solution make this my top reorder choice.

  4. Maisie Maeve –

    I requested separate purity certificates for every vial in my kit, support sent all certified files within one day. All samples test above 99% purity, so I skipped extra control experiments required for my academic research paper.

  5. Faye Z. –

    The molecular formula and molecular weight perfectly match the official specification sheet. This research-grade peptide has no extra fillers or impurities. As long as freezing is avoided, biological potency stays consistent month after month.

Add a review

Your email address will not be published. Required fields are marked *

PEPVERLABS / RESEARCH CATALOG

Find your research material.

30 research materialsPRODUCT NAME / CODE